Valuation Vasundhara Rasayans Limited

Stocks

Market Closed - Bombay S.E. 03:32:23 12/08/2026 pm IST			5-day change	1st Jan Change
173.60 ^INR	-4.51%		+0.14%	+2.06%

01/08	Vasundhara Rasayans Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026	CI
28/05	Vasundhara Rasayans Limited Enters Memorandum of Understanding Cum Loan-Lease Agreement with Pandj Cretechem Private Limited for Manufacturing of Active Pharmaceutical Ingredients	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	222.2	367.6	396.6	612.9	733.7	335.8
Change	-	65.45%	7.91%	54.53%	19.7%	-54.23%
Enterprise Value (EV) ¹	115.1	269.7	359.5	525.2	696.8	303.4
Change	-	134.23%	33.28%	46.09%	32.69%	-56.46%
P/E	7.57x	16.9x	7.09x	10.5x	17.4x	5.8x
PBR	1.12x	1.71x	1.48x	1.92x	2.06x	0.82x
PEG	-	-0.7x	0x	2.18x	-0.6x	0.2x
Capitalization / Revenue	0.98x	1.37x	1.05x	1.66x	2.16x	0.94x
EV / Revenue	0.51x	1.01x	0.95x	1.42x	2.05x	0.85x
EV / EBITDA	3.71x	12.1x	6.49x	7.94x	16.6x	5.22x
EV / EBIT	3.77x	12.8x	6.64x	8.27x	18.1x	5.64x
EV / FCF	3.29x	-40.6x	-4.4x	14.4x	-11x	-11.5x
FCF Yield	30.4%	-2.46%	-22.7%	6.96%	-9.11%	-8.7%
Dividend per Share ²	1.5	1	2	2	2	2
Rate of return	2.15%	0.86%	1.6%	1.04%	0.87%	1.89%
EPS ²	9.237	6.836	17.59	18.44	13.27	18.22
Distribution rate	16.2%	14.6%	11.4%	10.8%	15.1%	11%
Net sales ¹	226.8	267.5	379.4	370.2	339.9	357.2
EBITDA ¹	31.02	22.22	55.42	66.1	41.99	58.14
EBIT ¹	30.51	21.07	54.11	63.47	38.42	53.84
Net income ¹	29.36	21.73	55.91	58.59	42.46	57.89
Net Debt ¹	-107	-97.85	-37.16	-87.75	-36.87	-32.39
Reference price ²	69.90	115.65	124.80	192.85	230.85	105.65
Nbr of stocks (in thousands)	3,178	3,178	3,178	3,178	3,178	3,178
Announcement Date	03/09/21	06/09/22	07/08/23	08/09/24	04/09/25	01/08/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VASUNDHARA RASAYANS LIMITED	-	-	-	-	60.58L
ELI LILLY AND COMPANY	34.45x	12.59x	25.62x	0.57%	1,08300Cr
JOHNSON & JOHNSON	28.9x	-	-	2.07%	63TCr
ABBVIE INC.	31.93x	7.43x	15.44x	2.74%	44TCr
ROCHE HOLDING AG	20.56x	4.87x	12.07x	2.71%	36TCr
NOVARTIS AG	22.02x	5.7x	14.21x	2.82%	29TCr
ASTRAZENECA PLC	20.5x	4.23x	12.01x	2.08%	25TCr
AMGEN INC.	25.99x	6.83x	12.15x	2.43%	22TCr
NOVO NORDISK A/S	13.93x	4.99x	10.37x	3.65%	21TCr
GILEAD SCIENCES, INC.	-42.16x	6.03x	34.04x	2.43%	17TCr
Average	17.35x	6.58x	16.99x	2.39%	36.59TCr
Weighted average by Cap.	24.65x	8.25x	18.71x	1.96%